EMEA-001284-PIP01-12 - paediatric investigation plan
Tivantinib
PIPHuman
Daiichi Sankyo Development Limited
kourumova@dsd-eu.com
United Kingdom
+44 1753482813
+44 1753899107
P/0149/2012: EMA decision of 24 July 2012 on the refusal of a product specific waiver for tivantinib (EMEA-001284-PIP01-12)